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As the editorial points out, Kaiser—which began as a
prepaid medical group practise in 1946—is a region-
alized, integrated healthcare system in which mem-
bers are ‘locked-in’; that is, they must use Kaiser
clinics, Kaiser physicians and other providers, and
Kaiser hospitals for their care. A little history may be
useful in understanding Kaiser’s unique position in the
American healthcare marketplace. At first, Kaiser had
little competition—except from then-prevalent fee-for-
service (FFS), pay-as-you-go system and the small
number of closed panel Health Maintenance Organi-
zations (HMOs) that began to sprout in the mid-1970s.
However, with the shift away from traditional FFS serv-
ice medicine in the U.S. and the rapid proliferation of
new open-ended, point-of-service health plans, Kaiser
has had to figure out how to survive enormous com-
petitive pressures, including a deeply-held consumer
preference for free choice, and a stubborn physician
predilection for private solo practice. This market real-
ity has had a major impact on Kaiser. Over the years,
it has been forced to pull out of markets in the North
East, North Carolina and Texas. Today, Kaiser
remains concentrated in the West (California, Colorado,
Washington, Oregon, and Hawaii) and to a lesser
extent in the Mid-Atlantic region (Washington, DC and
Virginia), Ohio and Georgia. To stay competitive,
albeit in these core markets, Kaiser has had to rede-
sign its care processes—without sacrificing the overall
model. This has meant placing an emphasis on inte-
grated services, chronic care, patient self-manage-
ment, and the widespread use of health information
technology.
Despite these pace-setting, quality-enhancing chang-
es, Kaiser still looks ‘foreign’ to most Americans. It
may be that Kaiser’s time-tested model is a better ‘fit’
with the way care is to some extent already organized
and delivered in parts of Europe. This probably
explains the interest of the National Health Service
(NHS) in England. However, if the past is really a pro-
logue to the future, I predict that it will be just as dif-
ficult to ‘sell’ Kaiser or similar models in other parts of
Europe as it has been in most of the U.S. But, why
must Europeans ‘buy’ the Kaiser model whole hog? I
would argue that Europeans can find a way to benefit
from Kaiser’s many innovations in disease manage-
ment and other fields without institutionalizing the
model itself. As for the role of competition, I’m not sure
we can find very much evidence—at least in the
U.S.—that it produces the kind of positive results cited
in the editorial. Kaiser is the rare example. Indeed,
earlier efforts to develop integrated delivery systems
(IDSs) in the U.S. created a merger mania. However,
they failed disappointingly in terms of yielding
improved efficiency or health outcomes. Perhaps a
better place to look is Canada, where some regional
health agencies—like Capital Health in Edmonton,
Alberta—have successfully taken on responsibilities
for the provision of integrated, outcomes-oriented
health services—preventive, acute, long-term and
mental health care—in addition to the public health
function and the funding and regulation of the regional
health system itself.
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